HLS Therapeutics Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- HLS Therapeutics's estimated revenue is currently $7M per year.
- HLS Therapeutics received $125.0M in venture funding in September 2018.
- HLS Therapeutics's estimated revenue per employee is $171585
- HLS Therapeutics has 41 Employees.
- HLS Therapeutics grew their employee count by 14% last year.
- HLS Therapeutics currently has 1 job openings.
What Is HLS Therapeutics?
The Heritage of Life Sciences Products HLS Therapeutics is about maintaining the heritage of life science products. We are dedicated to keeping trusted branded drugs on the market. HLS provides access to medications critical to Health Care Providers, patients and their caregivers with the high-quality brand names they trust. Who We Are HLS Therapeutics Inc. is a specialty pharmaceutical company dedicating itself to acquiring and distributing commercial stage mature, or legacy, branded pharmaceutical drugs for the North American markets. Our management team is comprised of seasoned pharmaceutical executives with a strong track record of success. Building on the expertise of our founders, HLS is focused on treatment products for the central nervous system, soon to be followed by specialty products in other therapeutic areas. HLS Therapeutics focuses on the North American market and has operational locations in Toronto (Etobicoke, Ontario), and Philadelphia (Rosemont, Pennsylvania), We source our products from the drug's originator or from best-in-class manufacturing partners, ensuring our brands are manufactured with the highest standards of quality and in compliance with FDA and Health Canada's regulations. Our Goal/Our Mission HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycle during and post exclusivity, providing access to treatments critical to Health Care Providers, patients and their caregivers with the brand names they trust.keywords:N/A
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Fresenius Kabi ...||$19.8M||108||21%|
|Dalton Pharma S...||$23.1M||125||4%|
HLS Therapeutics Funding
|2018-09-13||$125.0M||Undisclosed||Silicon Valley Bank||Article|